Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 15Thoracic 2Gastrointestinal 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Ovarian Neoplasms 117Uterine Cervical Neoplasms 65Carcinoma, Ovarian Epithelial 64Fallopian Tube Neoplasms 62Endometrial Neoplasms 38Brenner Tumor 22Sarcoma 18Testicular Neoplasms 15Vulvar Neoplasms 12Squamous Intraepithelial Lesions 10Sarcoma, Endometrial Stromal 10Endometrial Adenocarcinoma 10Breast Neoplasms 10Ovarian Germ Cell Cancer 9HIV Infections 9Teratoma 7Sarcoma, Synovial 7Precancerous Conditions 7Osteosarcoma 7Neurofibrosarcoma 7Neuroblastoma 7Melanoma 7Liposarcoma 7Leiomyosarcoma 7Histiocytoma, Malignant Fibrous 7Hemangiosarcoma 7Fibrosarcoma 7Carcinoma, Non-Small-Cell Lung 7Uterine Cervical Dysplasia 6Stomach Neoplasms 6

Interventions

Tamoxifen 1Medroxyprogesterone 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Breast Carcinoma In Situ × Gynecologic × Clear all
NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
313 enrolled
BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡